Results 21 to 30 of about 37,807 (264)
SAGE Open, 2018 This article describes outcomes of the complex therapy of Parkinson’s disease according to Operation and Procedure Code 8-97d, an interdisciplinary approach to the treatment of Morbus Parkinson established in Germany.
Tobias Romeyke +3 more
doaj +1 more source
Arquivos de Neuro-Psiquiatria, 2022 Background: the diagnosis of Parkinson's disease (PD) can be challenging, especially in the early stages, albeit its updated and validated clinical criteria.
Rafael Tomio Vicentini Otani +4 more
doaj +1 more source
Dopamine Transporter Imaging for Distinguishing Between Idiopathic Parkinson’s Disease and Secondary Parkinsonism [PDF]
, 2012 Idiopathic Parkinson’s disease (IPD), first described by James Parkinson in 1817, is a sporadic neurodegenerative disorder. The main clinical features include masked face, resting tremor, bradykinesia, rigidity, festinating gait, and loss of postural reflexes. The clinical features are most insidious and usually asymmetric at onset.
Huang, Chin-Chang +2 more
openaire +2 more sources
The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis
Basic and Clinical Neuroscience, 2021 Introduction: An impaired sense of smell has a remarkable impact on the quality of life. It is seen in a variety of neurodegenerative diseases such as Parkinson disease.
Mostafa Almasi +4 more
doaj
Arquivos de Neuro-Psiquiatria, 2000 We describe a patient whose initial manifestation of Parkinson's disease was a malfunctioning of a self-winding wristwatch secondary to bradykinesia of his left arm.
HÉLIO A. G. TEIVE, DANIEL S. SÁ
doaj +1 more source
Secondary task performance during challenging walking tasks and freezing episodes in Parkinson’s disease [PDF]
Journal of Neural Transmission, 2016 Parkinson's disease (PD) patients likely use attentional strategies to compensate for their gait deficits, which increases the cognitive challenge of walking. The interplay between cognitive functions and gait can be investigated by evaluating the subject's attendance to a secondary task during walking.
Dibilio, V. +5 more
openaire +4 more sources
Interdisciplinary Neurosurgery, 2019 Hemiparkinsonism is an exceptionally rare form of secondary Parkinsonism that manifests with unilateral symptoms and is often accompanied by ipsilateral body atrophy.
Christopher A. Sarkiss, M.D. +6 more
doaj +1 more source
npj Parkinson's DiseaseParkinson's disease (PD) is characterized by progressive degeneration of dopaminergic neurons in the substantia nigra, while secondary parkinsonism (SP) may be due to drugs, vascular, infectious, inflammatory, or even paraneoplastic etiologies. There is currently no biomarker that accurately distinguishes SP from PD.
Hong-Qi Yang +11 more
openaire +3 more sources
Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system
FEBS Letters, EarlyView.Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley +1 more source
Impact of Disclosure of Individual Imaging Results in a Multi-Center Parkinson Clinical Trial
Journal of Parkinson’s Disease, 2014 Background: Little is known about the impact of providing individual research results to clinical trial participants or the impact of sharing such data.
Danna Jennings +6 more
doaj +1 more source